MicMac at DDL 2026. Because particle size is everything in inhalation.
In inhaled therapy, particle size is not a downstream detail — it defines where your molecule lands, how it performs, and whether your formulation works. It is a discipline that demands both scientific depth and manufacturing precision. That is exactly what MicMac is built for.
Micromacinazione will be at the 37th DDL Conference, stand 205. Our team is available to discuss micronization for DPI and MDI formulations, HPAPI handling with high-containment systems, particle size distribution design, and the path from feasibility batches to commercial scale.
Over 50 years of particle engineering experience. Three GMP-inspected sites in Monteggio, Switzerland. Capacity exceeding 1,000 tons/year. Certified by FDA, Swissmedic, and Japanese health authorities.
Come and find us at stand 205.
